BD Bluejay Diagnostics, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Bluejay Diagnostics, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Bluejay Diagnostics, Inc. has published 23 reports. Market capitalisation: €1.1m. The latest transaction was disclosed on 18 August 2026 (Attribution). Among the most active insiders: Dey Indranil. The full history is accessible without an account.
€258,883
12 ops.
Buy Volume
Buys €258,883 €42,726 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
All Executives23 Thresholds0 Prospectus0 Other0
Declarations 23 total
◆ President and CEO · Executives · 17 Aug 2026
28,000 shares 0Common Stock SEC:0001123292-26-001124:0
▲ 10% Owner · Executives · 9 Jul 2026
64,047 shares @ US$1.51 5.38% mcap 66.5% of flow Common Stock SEC:0001475597-26-000158:0
Canonical exit: 7 Oct 2026 (T+90) ▼ 10% Owner · Executives · 10 Jul 2026
34,938 shares @ US$1.40 2.72% mcap 33.5% of flow Common Stock SEC:0001475597-26-000158:1
▲ Director · Executives · 13 Dec 2023
500 shares @ US$3.07 4.5% of flow Common Stock SEC:0001062993-23-022569:0
Canonical exit: 12 Mar 2024 (T+90) ▲ President and CEO · Executives · 13 Dec 2023
500 shares @ US$3.27 2.1% of flow Common Stock SEC:0001062993-23-022568:0
Canonical exit: 12 Mar 2024 (T+90) ▲ President and CEO · Executives · 27 Mar 2023
8,000 shares @ US$0.44 4.5% of flow Common Stock SEC:0001213900-23-025243:0
Canonical exit: 25 Jun 2023 (T+90) ▲ Director · Executives · 24 Mar 2023
10,000 shares @ US$0.44 12.9% of flow Common Stock SEC:0001213900-23-025245:0
Canonical exit: 22 Jun 2023 (T+90) ◆ President and CEO · Executives · 27 Mar 2023
8,000 shares @ US$0.44 4.5% of flow Common Stock SEC:0001213900-23-023546:0
◆ Director · Executives · 24 Mar 2023
10,000 shares @ US$0.44 12.9% of flow Common Stock SEC:0001213900-23-022724:0
◆ Director · Executives · 1 Feb 2023
27,500 shares @ US$0.44 100.0% of flow Common Stock SEC:0001213900-23-012462:0
◆ Director · Executives · 1 Feb 2023
27,500 shares @ US$0.44 9.8% of flow Common Stock SEC:0001213900-23-010875:0
◆ Director · Executives · 1 Feb 2023
27,500 shares @ US$0.44 100.0% of flow Common Stock SEC:0001213900-23-010877:0
◆ Chief Financial Officer · Executives · 1 Feb 2023
112,500 shares @ US$0.44 53.8% of flow Common Stock SEC:0001213900-23-010880:0
◆ Director · Executives · 1 Feb 2023
27,500 shares @ US$0.44 35.5% of flow Common Stock SEC:0001213900-23-010887:0
◆ President and CEO · Executives · 1 Feb 2023
159,090 shares @ US$0.44 88.9% of flow Common Stock SEC:0001213900-23-010882:0
◆ Director · Executives · 1 Feb 2023
27,500 shares @ US$0.44 100.0% of flow Common Stock SEC:0001213900-23-010890:0
▲ Chief Financial Officer · Executives · 26 Aug 2022
20,000 shares @ US$1.03 24.4% of flow Common Stock SEC:0001213900-22-054434:0
Canonical exit: 24 Nov 2022 (T+90) ▲ Chief Financial Officer · Executives · 25 Apr 2022
20,000 shares @ US$0.99 21.8% of flow Common Stock SEC:0001213900-22-021923:0
Canonical exit: 24 Jul 2022 (T+90) ▲ Chief Financial Officer · Executives · 17 Mar 2022
2,500 shares @ US$1.159 22.4% of flow Common Stock SEC:0001213900-22-013794:0
Canonical exit: 15 Jun 2022 (T+90) ▲ Director · Executives · 17 Mar 2022
10,000 shares @ US$1.183 39.2% of flow Common Stock SEC:0001213900-22-013761:0
Canonical exit: 15 Jun 2022 (T+90) ▲ Director · Executives · 17 Mar 2022
40,000 shares @ US$1.178 37.7% of flow Common Stock SEC:0001213900-22-013510:0
Canonical exit: 15 Jun 2022 (T+90) ▲ Director · Executives · 16 Mar 2022
60,000 shares @ US$1.09 52.5% of flow Common Stock SEC:0001213900-22-013129:0
Canonical exit: 14 Jun 2022 (T+90) ▲ Chief Financial Officer · Executives · 14 Mar 2022
10,500 shares @ US$0.95 77.6% of flow Common Stock SEC:0001213900-22-013084:0
Canonical exit: 12 Jun 2022 (T+90) 关于 Bluejay Diagnostics, Inc. Bluejay Diagnostics, Inc. 是一家专注于开发医疗诊断解决方案的公司。它旨在通过创新技术改善医疗保健。